Lung cancer
Conditions
Interventions
experimental group:Intelligent sketch
Control group:manual sketch
Sponsors
Shanghai Pulmonary Hospital Affiliated to Tongji University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 to 75 years; 2. Patients with kappa score >= 70 and weight loss = 12 weeks; 6. Patients with good blood function: serum hemoglobin >=100g/L, platelet >=100x10^9/L, neutrophil absolute count >= 1.5x10^9/L; 7. Liver function: serum bilirubin = 60ml / min; 9. Patients of childbearing age agreed to use reliable methods of contraception before entering the study, during the study and within 90 days after drug withdrawal; 10. The patients who voluntarily joined the study and signed the informed consent form had good compliance and cooperated with the follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients who had received radical chest radiotherapy before; 2. Patients with pulmonary interstitial changes, COPD III and above; 3. Patients with postoperative radiotherapy for lung cancer; 4. Patients receiving concurrent radiotherapy and chemotherapy; 5. Patients with gemcitabine in the chemotherapy regimen before radiotherapy; 6. For patients with poor compliance in this study; 7. In the first 12 months of randomization, the patients with arteriovenous thrombosis events, such as cerebrovascular accident (including temporary ischemic attack, cerebral hemorrhage, cerebral infarction), deep vein thrombosis and pulmonary embolism, etc.; 8. Patients with a history of immune deficiency or other acquired, congenital immune deficiency diseases, or organ transplantation; 9. Other patients judged by the investigator not suitable for other situations in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy;recall;Incidence of radiation pneumonia; | — |
Countries
China
Contacts
Public ContactLiu Yu
Shanghai Pulmonary Hospital Affiliated to Tongji University
Outcome results
None listed